里格尔制药

最新新闻

• 评级变动
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/2/6
• 评级变动
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $81
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $83
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $83
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/4/24
• 评级变动
  H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Jefferies Initiates Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Announces Target Price $42
  \u5e02\u573a\u8d44\u8baf · 2025/11/6
• 评级变动
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $81
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Cuts Target Price to $69
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• H.C. Wainwright Sticks to Their Buy Rating for Rigel (RIGL)
  TipRanks · 2026/10/5
• 公司公告
  Rigel Pharmaceuticals: Rigel Pharmaceuticals, Inc. - Reverse Split Option Symbol: RIGL New Symbol: RIGL1
  OCC · 2024/6/26
• 评级变动
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71
  \u5e02\u573a\u8d44\u8baf · 2026/3/4
• 评级变动
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/3/4
• H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $38
  \u5e02\u573a\u8d44\u8baf · 2025/11/5
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on Rigel (RIGL)
  TipRanks · 2026/1/28
• H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $85
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43
  \u5e02\u573a\u8d44\u8baf · 2026/8/5

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。